title: [Effect of mannitol on serum tumor necrosis factor-α and interleukin-6 levels and the mechanism of its organ-protective effect in rabbits early after severe burn injury].
abstract: OBJECTIVE
  To investigate the protective effect of mannitol therapy on the vital organs and explore the underlying mechanisms in New Zealand rabbits with severe burn injury.
  
  
  METHODS
  Twelve New Zealand rabbits with severe burn injury (30% of TBSA) were randomized to receive fluid resuscitation with saline (control) or mannitol therapy starting at 1 h after the injury. Serum and urine samples were collected before and at 1, 4, 8, 24, and 48 h after the injury for detection of TNF-α, IL-6, ALT, AST, GGT, CK, CK-MB, BUN and Cr levels using sandwich ELISA.
  
  
  RESULTS
  One hour after sever burn injury, the serum levels of TNF-α and IL-6 began to increase along with ALT, AST, GGT, CK, CK-MB, BUN and Cr levels. Compared with control group, the rabbits in mannitol group showed significantly higher 48 h urine excretion of TNF-α (145 ± 8 vs 78 ± 1 0 pg/ml, P<0.05) and IL-6 (93 ± 6 vs 40 ± 8 pg/ml, P<0.05) but with lowered serum levels of TNF-α (0.62 ± 0.02 vs 0.83 ± 0.02 pg/ml, P<0.05) and IL-6 (0.45 ± 0.03 vs 0.56 ± 0.03 pg/ml, P<0.05) as well as lowered serum ALT, AST, GGT, CK, CK-MB, BUN and Cr levels (P<0.05).
  
  
  CONCLUSIONS
  In rabbits with severe burn injury, mannitol therapy can decrease serum TNF-α and IL-6 levels early after the injury to ameliorate potential functional impairment of the heart, liver and kidneys.
authors: Frist Affiliated Hospital of Guangzhou Medical College, China. 937229461@qq.com
authors: Rong
authors: R
authors: Liang
authors: Xinzhou
authors: X
authors: Rong
authors: Tao
authors: T
authors: Zhang
authors: Yan
authors: Y
authors: Shen
authors: Libing
authors: L
authors: Dai
authors: Yue
authors: Y
authors: Huang
mesh_terms: D000818:Animals; D002056:Burns / Q000097:blood* / Q000188:drug therapy*; D005440:Fluid Therapy; D015850:Interleukin-6 / Q000097:blood*; D008297:Male; D008353:Mannitol / Q000627:therapeutic use*; D011817:Rabbits; D014409:Tumor Necrosis Factor-alpha / Q000097:blood*
chemical_list: D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D008353:Mannitol